Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Drug Names Tentatively Accepted As Trademarks Could Be Placed On Internet

This article was originally published in The Tan Sheet

Executive Summary

FDA is thinking of making tentatively accepted drug trade names viewable on the Internet

You may also be interested in...



FDA review of drug names

Drug Safety & Risk Management Advisory Committee will convene Dec. 4 to "discuss current screening methods to assess sound alike and look alike proprietary drug names, in order to reduce the incidence of medication errors." Meeting, previously scheduled for Sept. 18-19, was postponed for weather-related reasons. Session will follow-up on topics explored at a June meeting co-sponsored by FDA, PhRMA and the Institute for Safe Medication Practices (1"The Tan Sheet July 7, 2003, p. 12). Panel will meet at the Holiday Inn in Gaithersburg, from 8 am to 5 pm...

FDA review of drug names

Drug Safety & Risk Management Advisory Committee will convene Dec. 4 to "discuss current screening methods to assess sound alike and look alike proprietary drug names, in order to reduce the incidence of medication errors." Meeting, previously scheduled for Sept. 18-19, was postponed for weather-related reasons. Session will follow-up on topics explored at a June meeting co-sponsored by FDA, PhRMA and the Institute for Safe Medication Practices (1"The Tan Sheet July 7, 2003, p. 12). Panel will meet at the Holiday Inn in Gaithersburg, from 8 am to 5 pm...

FDA review of drug names

Drug Safety & Risk Management Advisory Committee will convene Dec. 4 to "discuss current screening methods to assess sound alike and look alike proprietary drug names, in order to reduce the incidence of medication errors." Meeting, previously scheduled for Sept. 18-19, was postponed for weather-related reasons. Session will follow-up on topics explored at a June meeting co-sponsored by FDA, PhRMA and the Institute for Safe Medication Practices (1"The Tan Sheet July 7, 2003, p. 12). Panel will meet at the Holiday Inn in Gaithersburg, from 8 am to 5 pm...

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095653

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel